Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The higher adherence to the DASH diet the lower incidence and mortality from cardiovascular disease and all causes: ELSA-Brasil study.

Created on 19 Oct 2026

Authors

Saionara C Francisco, Sandhi M Barreto, Carolina Gomes Coelho, Lidyane do Valle Camelo, Sheila Maria Alvim de Matos, Vivian Cristina Luft, Álvaro Vigo, Maria Inês Schmidt, Luana Giatti

Published in

International journal of food sciences and nutrition. Pages 1-11. Oct 18, 2026. Epub Oct 18, 2026.

Abstract

To investigate the association between adherence to the Dietary Approaches to Stop Hypertension (DASH) diet and major adverse cardiovascular events (MACE), cardiovascular disease (CVD) mortality and all-cause mortality. The study included 14,621 participants from the ELSA-Brasil cohort. DASH adherence was assessed at baseline using a continuous score. Fine-Gray competing risk models were for MACE and CVD mortality, and Cox models for all-cause mortality. Models were adjusted for sociodemographic factors, behaviours, comorbidities, weight change, and total energy intake. Mean age was 52 years (SD 9), and mean DASH score was 23.9 (SD 4.4). Each one-point increase in the DASH score was associated with lowerrisk of MACE (sHR 0.96; 95% CI 0.92-0.99), CVD mortality (sHR 0.95; 95% CI 0.92-1.00), and all-cause mortality (HR 0.97; 95% CI 0.95-0.98). Greater DASH adherence was associated with lower incidence of MACE and reduced CVD and all-cause mortality in Brazilian adults.

PMID:
42894272
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement